Noradrenergic response to intravenous yohimbine in patients with depression and comorbidity of depression and panic

Biol Psychiatry. 1993 Oct 15;34(8):558-61. doi: 10.1016/0006-3223(93)90199-n.

Abstract

Adrenergic response following infusions of yohimbine or normal saline was evaluated in 9 control subjects, 8 patients suffering from a major depressive episode (MDE), and 12 patients suffering from concurrent MDE and panic disorder (MDE + P). Blood was drawn at -20, 0, 5, 10, 20, 45, and 90 min following the infusions, and assayed for norepinephrine (NE) and 3-methoxy-4-hydroxy-phenyl glycol (MHPG). Although the patient groups exhibited higher baseline NE concentrations, and a greater NE area under the plasma concentration versus time curve (AUC0-90) during the yohimbine infusion, the differences were not statistically significant. Baseline NE was significantly correlated with the NE AUC0-90 in all three groups, suggesting that, although the NE system may be dysregulated in the MDE and MDE + P patients, the NE system still appears to respond somewhat predictably following a challenge, even though the actual magnitude of response may vary.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Comorbidity
  • Depressive Disorder / blood*
  • Depressive Disorder / psychology
  • Double-Blind Method
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Methoxyhydroxyphenylglycol / blood
  • Middle Aged
  • Norepinephrine / blood*
  • Panic Disorder / blood*
  • Panic Disorder / psychology
  • Receptors, Adrenergic, alpha-2 / drug effects*
  • Receptors, Adrenergic, alpha-2 / physiology
  • Yohimbine / pharmacology*

Substances

  • Receptors, Adrenergic, alpha-2
  • Yohimbine
  • Methoxyhydroxyphenylglycol
  • Norepinephrine